Hanham Ann

Avg. Two Year Performance

(24%) Avg. Purchase Return
(12%) Compound
23% Avg. Sale Return
11% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(17%)(10%)< 1%(26%)(24%)
Purchase Success Rate0 of 20 of 21 of 20 of 20 of 2
Average Sale Return(8%)(32%)(13%)(46%)23%
Sale Success Rate1 of 20 of 21 of 21 of 22 of 2

BioMimetic Therapeutics Inc.

Health Services » Medical Instruments & Supplies

Director, 10% Owner:

Holdings: 2.35M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Immunicon Corp

Electronics » Scientific & Technical Instruments

Director:

Holdings: 1.17M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Targacept, Inc.

Drugs » Biotechnology

Director:

Holdings: 779.06K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Endocyte, Inc.

Drugs » Drug Manufacturers - Major

Director:

Holdings: 7.8K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

SCYNEXIS, Inc.

Drugs » Drugs - Generic

Director:

Holdings: 46.62K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Htg Molecular Diagnostics, ...

Health Services » Medical Laboratories & Research

Director:

Holdings: 7.3K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--